Skip to main content
Premium Trial:

Request an Annual Quote

People Transfer: Feb 25, 2009

Premium

The Johns Hopkins Institute for NanoBioTechnology has named Thomas Fekete as its new director of corporate partnerships.

Fekete will act as a liaison between INBT faculty researchers and industry representatives, and will work to facilitate technology transfer from INBT-affiliated labs. Prior to joining Johns Hopkins, Fekete most recently worked for KV Pharmaceuticals as director of operations projects. Prior tot hat, he directed manufacturing sites for Astaris and held executive-level positions in research, engineering, and manufacturing for the chemicals operations of FMC Corporation in Baltimore and Philadelphia.

Fekete holds a master's degree in chemical engineering from Johns Hopkins and a bachelor's degree in chemical engineering from Rensselaer Polytechnic Institute.


UW TechTransfer, the commercialization arm of the University of Washington, last week said that it recruited the initial members of two new services under its LaunchPad commercialization program: an Entrepreneur-in-Residence program and an Entrepreneur Advisor program.

UW has recruited the following executives during the initial phase of the Entrepreneur-in-Residence program:

Alex St. John, a former Microsoft executive and co-inventor of the DirectX gaming platform. St. John also co-founded online gaming network Wild Tangent.

Deborah Kessler, a former Merck executive and COO of Rosetta Informatics

Jeff Canin, who has formerly served as an associate at US Venture Partners, a venture capitalist for eFund, an investment banker at Dain Rauscher, and co-founder of the Center for Smart Energy

The first group of Entrepreneur Advisors includes:

Joe Eichinger, co-founder and president of CoAptus Medical

Bill Grossman, former CEO of Revenue Science

John Hansen, former CEO of Vallent

Michael Hovanes, a medical device and imaging entrepreneur

Will Poole, a former Microsoft vice president

Chris Porter, formerly of CellPro and Pfizer

Sterling Wilson, former president of Qpass and executive at Concur Technologies

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.